Wolfgang Oster

About

Wolfgang is the Managing Partner for the Life Science Fund. He is a dual citizen of the U.S. and Germany and throughout his academic, industry and investor career he has worked "across the Atlantic" and combined the best of Europe with the capabilities unique to the U.S. His successful track record as entrepreneur, executive and investor includes two major trade sales (U.S. BioScience, BiPar), and 5 IPOs (Devgen, Jerini, Micrus, OncoMethylome, Addex). Wolfgang is the previous Chairman and current board member of Cappella (Galway, Boston, and Bangalore), previous Chairman and current board member of Intelligent Medical Implants (Bonn and Zug), Executive Chairman of ImmunoGenes (Budapest and Zug), Executive Chairman of Hemacon (Düsseldorf and Bangalore), Chairman and founder CEO of Oncoceutics (Philadelphia), Chairman at Provid (New Brunswick), Chairman and Co-Founder at Noblegen (Boston). As an executive and investor Wolfgang oversaw the successful developments and market introductions

Investment Focus